Turing Biosystems
Turing Biosystems helps clinicians and biopharma reduce toxicities and failure rates in immunotherapy and cell and gene therapies by designing patient-specific interventions. It uses an interpretable AI platform based on automated reasoning and specialized chips to integrate multimodal clinical and biological data, including EHR metadata, lab results, and cohort-level datasets. The product is offered as B2B software for clinical teams and biopharma R&D to analyze patient responses and optimize treatment selection. The platform integrates with clinical data sources and supports both individual- and cohort-level analyses to inform therapeutic decisions. Turing Biosystems targets the clinical and cell/gene therapy market where adverse immune responses and high trial attrition are major challenges.
Turing Biosystems
Turing Biosystems helps clinicians and biopharma reduce toxicities and failure rates in immunotherapy and cell and gene therapies by designing patient-specific interventions. It uses an interpretable AI platform based on automated reasoning and specialized chips to integrate multimodal clinical and biological data, including EHR metadata, lab results, and cohort-level datasets. The product is offered as B2B software for clinical teams and biopharma R&D to analyze patient responses and optimize treatment selection. The platform integrates with clinical data sources and supports both individual- and cohort-level analyses to inform therapeutic decisions. Turing Biosystems targets the clinical and cell/gene therapy market where adverse immune responses and high trial attrition are major challenges.